comparemela.com
Home
Live Updates
Oral Simufilam - Breaking News
Pages:
Latest Breaking News On - Oral simufilam - Page 1 : comparemela.com
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
An Independent Data and Safety Monitoring Board Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 Trials.
United states
Puerto rico
South korea
Eric schoen
Remi barbier
Cassava sciences
Research international
Cassava sciences inc
Safety monitoring board
Recently evaluated
Interim patient safety database
Oral simufilam
On going phase
Both phase
Clinical safety data
Simufilam are expected
SAVA250620P00012500 (SAVA250620P00012500) Interactive Stock Chart
Interactive Chart for SAVA250620P00012500 (SAVA250620P00012500), analyze all the data with a huge range of indicators.
United states
Cassava sciences inc
International conference on alzheimer
International conference
Oral simufilam
Mild to moderate alzheimer
Baseline characteristics
SAVA240426P00019000 (SAVA240426P00019000) Interactive Stock Chart
Interactive Chart for SAVA240426P00019000 (SAVA240426P00019000), analyze all the data with a huge range of indicators.
United states
Cassava sciences inc
International conference on alzheimer
International conference
Oral simufilam
Mild to moderate alzheimer
Baseline characteristics
SAVA240315C00017000 (SAVA240315C00017000) Interactive Stock Chart
Interactive Chart for SAVA240315C00017000 (SAVA240315C00017000), analyze all the data with a huge range of indicators.
United states
International conference on alzheimer
Cassava sciences inc
International conference
Oral simufilam
Mild to moderate alzheimer
Baseline characteristics
Interactive chart
Data graph
Data points
Data analysis
vimarsana © 2020. All Rights Reserved.